Erythropoietin may improve anemia in patients with autoimmune hemolytic anemia associated with reticulocytopenia. (otvara se novi prozor)

Arbach O, Funck R, Seibt F, Salama A.

Izvor‎: Transfus Med Hemother 2012;39(3):221-3.

Indeks‎: PubMed 22851939

DOI‎: 10.1159/000339260

https://www.ncbi.nlm.nih.gov/pubmed/22851939 (otvara se novi prozor)

The changing spectrum of drug-induced immune hemolytic anemia. (otvara se novi prozor)

Arndt PA, Garratty G.

Izvor‎: Semin Hematol 2005;42(3):137-44.

Indeks‎: PubMed 16041663

https://www.ncbi.nlm.nih.gov/pubmed/16041663 (otvara se novi prozor)

Low-dose rituximab in adult patients with idiopathic autoimmune hemolytic anemia: clinical efficacy and biologic studies. (otvara se novi prozor)

Barcellini W, Zaja F, Zaninoni A, Imperiali FG, Battista ML, Di Bona E, Fattizzo B, Consonni D, Cortelezzi A, Fanin R, Zanella A.

Izvor‎: Blood 2012;119(16):3691-7.

Indeks‎: PubMed 22267606

DOI‎: 10.1182/blood-2011-06-363556

https://www.ncbi.nlm.nih.gov/pubmed/22267606 (otvara se novi prozor)

Autoimmune hemolytic anemia. (otvara se novi prozor)

Gehrs BC, Friedberg RC.

Izvor‎: Am J Hematol 2002;69(4):258-71.

Indeks‎: PubMed 11921020

https://www.ncbi.nlm.nih.gov/pubmed/11921020 (otvara se novi prozor)

Low-dose rituximab and alemtuzumab combination therapy for patients with steroid-refractory autoimmune cytopenias. (otvara se novi prozor)

Gómez-Almaguer D, Solano-Genesta M, Tarín-Arzaga L, Herrera-Garza JL, Cantú-Rodríguez OG, Gutiérrez-Aguirre CH, Jaime-Pérez JC.

Izvor‎: Blood 2010;116(23):4783-5.

Indeks‎: PubMed 20841509

DOI‎: 10.1182/blood-2010-06-291831

https://www.ncbi.nlm.nih.gov/pubmed/20841509 (otvara se novi prozor)

A case of late-onset systemic lupus erythematosus with severe anemia. (otvara se novi prozor)

Matsumoto M, Kaieda S, Honda S, Ida H, Hoshino T, Fukuda T.

Izvor‎: Kurume Med J 2013;60(1):25-8.

Indeks‎: PubMed 23925156

https://www.ncbi.nlm.nih.gov/pubmed/23925156 (otvara se novi prozor)

High-dose cyclophosphamide for refractory autoimmune hemolytic anemia. (otvara se novi prozor)

Moyo VM, Smith D, Brodsky I, Crilley P, Jones RJ, Brodsky RA.

Izvor‎: Blood 2002;100(2):704-6.

Indeks‎: PubMed 12091370

DOI‎: 10.1182/blood-2002-01-0087

https://www.ncbi.nlm.nih.gov/pubmed/12091370 (otvara se novi prozor)

Anti-CD20 monoclonal antibody for the treatment of severe, immune-mediated, pure red cell aplasia and hemolytic anemia. (otvara se novi prozor)

Zecca M, De Stefano P, Nobili B, Locatelli F.

Izvor‎: Blood 2001;97(12):3995-7.

Indeks‎: PubMed 11389047

https://www.ncbi.nlm.nih.gov/pubmed/11389047 (otvara se novi prozor)

Rituximab for the treatment of refractory autoimmune hemolytic anemia in children. (otvara se novi prozor)

Zecca M, Nobili B, Ramenghi U, Perrotta S, Amendola G, Rosito P, Jankovic M, Pierani P, De Stefano P, Bonora MR, Locatelli F.

Izvor‎: Blood 2003;101(10):3857-61.

Indeks‎: PubMed 12531800

DOI‎: 10.1182/blood-2002-11-3547

https://www.ncbi.nlm.nih.gov/pubmed/12531800 (otvara se novi prozor)